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ABSTRACT
Mental health disorders are a universal issue and affect millions of individuals every
day. Anxiety is the most common type of mental disorder, affecting social, physical, and
cognitive health. Although clinicians usually suggest prescriptive medications, they
carry side effects, are expensive, and only acutely alleviate symptoms. As a result, recent
interest has been directed towards nonconventional dietary therapies, including tea and
its constituent L-theanine, for anxiolytic effects. Tea is the most prevalent beverage
consumed after water; it is historically and globally accepted. The purpose of this
literature review is to explore whether tea and its constituent L-theanine carry anxiolytic
effects. To identify research in human subjects, PubMed was searched for human studies
from 1999 through 2014 of the relation between tea, its constituent L-theanine, and
anxiety. Seven studies (2 cross-sectional, 5 clinical) were identified as relevant to
measuring anxiety either subjectively or objectively. Three clinical studies showed an
effect of tea and L-theanine on anxiety, however they lacked sufficient quality to give
confidence of a cause-effect relationship. Stronger studies showed show an inconsistent
relationship between tea and its constituent, L-theanine, on anxiety.
Due to anxiety’s high prevalence and health consequences, more clinical trials using
systematic measurements for assessing exposures and outcomes in a large number of
subjects need to be undertaken. One key research question that persists is whether Ltheanine in isolation is similar to L-theanine found in tea. More valid research is needed
before definite conclusions can be made about the consumption of tea and its
constituent, L-theanine, for anxiolytic properties.
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Introduction
Mental health disorders are a worldwide issue that affect 12% of individuals at
some point during their lives (Kessler et al., 2009) and 7.3% of the global population at
any given time (Baxter, Vos, Scott, Ferrari, & Whiteford, 2014). Mental disorders
include anxiety, mood, impulse control, and substance abuse disorders. Disorders are
specifically widespread in the United States and impact 30% of the adult population,
with anxiety the most prevalent disorder at 18.1%. It is expected that anxiety will affect
28.8% of individuals in the United States for at least a 12-month span (Kessler, Chiu,
Demler, Merikangas, & Walters, 2005). Some of the many detrimental consequences of
anxiety include an overall lower quality of life, leading to impaired physical health,
disturbed social relationships, and a decreased function at work (Olatunji, Cisler, &
Tolin, 2007).
Current treatments for anxiety include cognitive, behavioral, and
pharmacological approaches (Barlow, 2004). Non-traditional approaches include
nutritional therapy and dietary supplements. A recently proposed dietary treatment for
anxiety is tea and its constituent L-theanine (Kimura, Ozeki, Juneja, & Ohira, 2007).
Recent research suggests that tea may have a positive effect on mental health and mood.
Tea may also be beneficial to physical health since it contains bioactive compounds that
may potentially reduce the risk of cardiovascular disease, cancer, and diabetes
(Matthews, 2010). Besides water, tea is a traditional part of lifestyle and is the most
frequently consumed beverage internationally (Matthews, 2010).
Historically, tea has been associated with comfort and relaxation. However, it
has only recently been studied whether tea and its constituent L-theanine truly lowers
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psychological stress (Einöther & Martens, 2013). The purpose of this literature review is
to investigate whether tea and its constituent L-theanine carry anxiolytic effects. The
majority of this paper will explore human studies of the effects of tea and L-theanine on
anxiety. First, however, an anxiety overview will be presented, including its definition,
diagnosis, complications, and treatments. Tea varieties, consumption data, and health
effects will also be described.
Anxiety Overview
Definition & Prevalence
Anxiety is a mood state characterized by irrational anticipation and sensitivity
towards futuristic threats (American Psychiatric Association [APA], 2013). Mild or brief
anxiety may be considered as a normal response to stress. However, anxiety disorders
are severely debilitating. They last at least 6 months and lead to a host of mental,
physical, and social health issues (Craske et al., 2009). Anxiety disorders are separated
into multiple subcategories including generalized anxiety, panic, post-traumatic stress,
social anxiety, and obsessive-compulsive disorder (National Institute of Mental Health
[NIMH], 2009).
Around 40 million, or 18%, of American adults are currently suffering with an
anxiety disorder. The lifetime prevalence of having an anxiety disorder in the United
States is 28.8%. Anxiety disorders currently affect nearly 8% of teenagers (NIMH,
2009). Figure 1 further specifies the percentages of various age groups that have an
anxiety disorder in America. Evidently, it is most common for individuals ages 30-44 to
have an anxiety disorder, and least common for those older than 60 to have an anxiety
disorder.
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Figure 1. Adults by age group and their percentage lifetime prevalence of having an
anxiety disorder. From National Institute of Mental Health, 2005.

Overall,
verall, 19 million Americans have a phobia, 15 million Americans are
diagnosed with social anxiety disorder, almost eight million carry post-traumatic
traumatic stress
disorder, nearly seven millionn Americans are diagnosed with generalized anxiety
disorder,, six million are affected by panic ddisorder, and over two million have
obsessive-compulsive
compulsive disorder (Anxiety and Depression Association of America
[ADAA], 2014a).. About two thirds of these individuals do not receive aany
ny treatment and
daily experience the many complications of anxiety (NIMH, 2009).
Etiology
Combinations of mental, environmental, developmental, and genetic components
are suggested to cause anxiety (NIMH, 2009). Anxiety mainly arises from brain regions
regi
called the amygdala and hippocampus. The amygdala responds to a threatening
ening situation
by generating fear. The hippocampus then encodes this fearful response into emotional
memories. Stored memories of this negative event can trigger feelings of threat and
anxiety. Chronic and excessive cases of anxiety are termed anxiety disorders (NIMH,
2009).
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Diagnosis
In order to determine whether an individual has an anxiety disorder, a skilled
physician must carefully analyze and evaluate symptoms that an individual is
experiencing (NIMH, 2009). Most physicians rely on the Diagnostic and Statistical
Manual of Mental Disorders (DSM-5) to diagnose an anxiety disorder (Craske et al.,
2009). Due to the separate diagnostic criteria for individual anxiety subtypes, the
diagnosis of anxiety with the DSM criteria is complicated to summarize. However,
example criteria for generalized anxiety disorder will be given. Criteria include
difficulty in managing worry; an extreme apprehension about normal circumstances;
worry that disturbs everyday functioning; anxiety that is not due to another medical or
physiological occurrence; an issue is not more properly defined by another
psychological disorder; and a state that exhibits at least three of the subsequent
manifestations: restlessness, lethargy, problems with focusing, annoyance, muscular
tension, and sleep issues (APA, 2013). Criteria common to all disorders are based on
self-report and include panic, self-restraint, perspiration, nausea, cardiac palpitations,
muscle tightness, and tremor (Craske et al., 2009). Although anxiety shares many
comparable symptoms with other mental disorders like depression, physiological
hyperarousal is a distinguishing characteristic that separates an anxiety disorder apart
from other mental disorders (Craske et al., 2009).
Due to the complex features of anxiety disorders, psychological questionnaires
can aid a physician in diagnosing a patient with an anxiety disorder (Craske et al., 2009).
Disorder-specific scales are used in research settings and accurately indicate the severity
of psychological distress (APA, 2013). Disorder-specific scales can also address any
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changes in the severity of an anxiety disorder. Multiple scales have been created for
different sets of focus, including the measurement of cognitive, behavioral, and physical
symptoms (APA, 2013). Specific anxiety tests that are commonly used for research
purposes will now be discussed.
Questionnaire-based anxiety tests. The State-Trait Anxiety Inventory
Questionnaire (STAI) is a universal instrument that relies on two separate anxiety levels,
state and trait anxiety, to measure the level of psychological distress. The STAI has two
sections with twenty questions each, with answer options using a 4-point Likert scale.
Scores range from 20 to 80 for each section (American Psychological Association,
2014). Subscores above 40 are suggested to indicate symptoms of anxiety, with higher
numbers indicating more extreme anxiety disorder cases. Since this test is considered to
be one of the most consistent, reliable, and valid, it is one of the most widely used
instruments in research settings (Julian, 2011).
The Beck Anxiety Inventory (BAI) emphasizes the cognitive, subjective, and
objective indications of anxiety (Beck & Steer, 1990). Using a 4-point Likert scale, the
21 multiple-choice questions ask about symptoms specific to anxiety and help
distinguish anxiety from depression. Each question ranges from 0-3 points and
contributes to the maximum score of 63. Summative scores of 21 or less illustrate
minimal anxiety, scores ranging from 22-35 suggest moderate anxiety, and scores above
36 indicate that someone has severe anxiety. Like the STAI, the BAI is demonstrated to
have sound consistency, validity, and reliability (Beck & Steer, 1990).
Scale-based anxiety tests. Another common means of measuring anxiety levels is
the Visual Analogue Mood Scale (VAMS) by Robert Stern (Stern, Arruda, Hooper,
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Wolfner & Morey, 1997). In the VAMS, individuals describe how they feel by marking
lines across various emotional statements or neutral symbolic faces. This scale has a
greater variety of response options when compared to a multiple-choice questionnaire.
Consequently, health experts may be more likely to recognize subtle changes in mood
behavior (Stern et al., 1997). Eight specific mood states are analyzed and scored from 0100 by measuring the distance with a ruler on the marked line. Scores are adjusted into
gender- and age-specific T-scores. If the measure of the fear scale is above 60T-70T, an
individual is suggested to have an anxiety disorder (McCallum, 2003). This method is
rapid, easy to administer, and simple to fill out (Stern et al., 1997).
A test similar to the VAMS is the Bond-Lader scale. The Bond-Lader scale is a
self-reported questionnaire that measures subjective feelings with a series of 16 visual
analogue scales (VAS) (Bond & Lader, 1974). This scale measures current anxious
feelings and physiological functioning through measures of alertness, calmness, and
contentedness. Subjects mark along a 100 mm scale that is juxtaposed with moodrelated adjectives. Scales are measured with a ruler and compared with the mean score in
the given manual (Bond & Lader, 1974). Scoring below the average for calmness and
contentedness and above the average for alertness may indicate that an anxiety disorder
is present. When compared to conventional scales, the Bond-Lader scale offers a wider
variety of categorical responses and is therefore suggested to carry greater accuracy
(Bond & Lader, 1974).
The Kessler Psychological Distress Scale (KPDS) is a quick, easy, and validated
questionnaire measuring level of psychological distress (Kessler et al., 2003). It is based
on contemporary psychometric theory and can include a various amount of questions
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(Hozawa et al., 2009). In the 6-item scale test (K-6), an individual answers six questions
on whether they feel a certain way “all of the time” (4 points) to “none of the time” (0
points). Out of the total 24 points, individuals with 13 points or higher are suggested to
have psychological distress (Hozawa et al., 2009). In the 10-question scale test (K-10),
the patient answers 10 questions scored on a scale from 1-5 and selects if they feel a
certain way none, a little, some, most, or all of the time. If the patient scores 20 or
above, he or she is suggested to carry a mild mental disorder, with higher scores
associated with severity of psychological distress (Kessler et al., 2003).
Risk Factors
Certain populations are at a higher risk for developing an anxiety disorder
(NIMH, 2009). Non-modifiable risk factors, such genetics, race, and gender, play an
important role in determining the development of an anxiety disorder. Hispanics have a
30% lower risk and African Americans carry a 20% lower risk of developing the
disorder compared with Caucasians (NIMH, 2009). Compared to males, females have a
60% increased likelihood of developing any kind of anxiety disorder (NIMH, 2009) and
are twice as likely to develop phobias, generalized anxiety disorder, and panic disorder
(ADAA, 2014a).
Additionally, individuals who have another psychiatric disorder, physical illness,
or suffer with substance abuse are more likely to carry an anxiety disorder (NIMH,
2009). Specifically, depression is commonly associated with anxiety disorder: almost
half of individuals with depression also have an anxiety disorder (ADAA, 2014a).
Individuals who experience highly traumatic events, such as child sexual abuse, are also
more likely to develop an anxiety disorder. For instance, 65% of men and almost 50% of
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women who are sexually assaulted develop post-traumatic stress disorder (ADAA,
2014a). Additionally, individuals who are divorced or have been diagnosed with severe
medical conditions are at a higher risk of developing an anxiety disorder (National
Institutes of Health, 2014).
Consequences and Complications of the Disorder
At nearly one third of America’s mental health bill, anxiety disorders annually
cost the country $42 billion (ADAA, 2014a). Anxiety is a comorbid condition and
individuals diagnosed with an anxiety disorder have a 3-5 times higher likelihood of
seeking medical care for various health complications. Physiological complications
include lightheadedness, fainting, and gastrointestinal distress (ADAA, 2014a). Chronic
pain disorders, like arthritis and migraines, are also very common in individuals with
anxiety disorder (ADAA, 2014b). Clinical illnesses including respiratory disease,
cardiovascular disease, and gastrointestinal disorders are attributed to anxiety disorders
(Harvard Medical School, 2008). In particular, anxiety disorders have been shown to be
highly associated with cardiovascular disease. Women with the highest anxiety have
been shown to be 59% more likely to experience and 31% more likely to die from a
myocardial infarction than women with the lowest anxiety (Albert, Chae, Rexrode,
Manson, & Kawachi, 2005).
Additional complications can result from anxiety triggering other psychological
disorders. One example of a mental disorder is somatoform disorder, which is when an
individual has unexplainable physical symptoms that are suggested to solely arise from
mental illness. Common somatoform disorders include hypochondriasis, conversion
disorder, and body dysmorphia (Harvard Medical School, 2008). Body dysmorphia can
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lead to disturbances with eating, where almost half of individuals have history of an
anxiety disorder prior to the onset of their eating disorder (ADAA, 2014b). Other mental
disorders that can arise from anxiety include bipolar disorder, sleep disorder, attention
deficit hyperactive disorder, and depression (ADAA, 2014a).
Treatments for Anxiety
Anxiety disorders are most commonly treated with psychotherapy, prescription
drugs, or a combination of the both. For most individuals, combining psychotherapy
with medication is considered to be the best treatment (NIMH, 2009). Psychotherapy,
commonly known as counseling, is the practice of therapeutic interaction with a mental
health professional. Psychotherapy usually involves cognitive-behavioral therapy, an
approach that helps individuals change the way they think and react in fearful situations
(NIMH, 2009). Other common therapies include acceptance and commitment therapy,
exposure therapy, and dialectical behavioral therapy (ADAA, 2014c).
Prescriptions drugs are also used to treat, but not cure, anxiety disorders (NIMH,
2009). The medications alleviate major symptoms of psychological and physiological
distress. Benzodiazepines are the most common psychoactive drugs for anxiety disorder
(NIMH, 2009). Benzodiazepines include the medications alonazepam, iorazepam, and
alprazolam. Clinicians also prescribe antidepressants and beta-blockers for the treatment
of anxiety disorder (NIMH, 2009). However, these treatments do not alleviate symptoms
with all individuals. The medications may produce adverse side effects that include
fatigue, sexual malfunction, gastrointestinal issues, hypotension, and fluctuations in
weight. Further issues involve tolerance, dependence, and a high expense for doctors
visits and prescriptions (NIMH, 2009).
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Due to the high expense of prescription medication and its unwanted side effects,
nonconventional therapies are receiving increasing universal interest (Lakhan & Vieira,
2010). Acupuncture, aromatherapy, and mindfulness-based medication are more familiar
types of complementary and alternative medicine for treating anxiety (Van der Watt,
Laugharne, & Janca, 2008). Nontraditional approaches also involve dietary practices and
supplements (Lakhan & Vieira, 2010). Common supplements include kava,
passionflower, L-lysine, and L-arginine. Although some scientific evidence supports the
use of these supplements for the reduction of anxiety disorder symptoms, these
treatments are not a proven therapy (Lakhan & Vieira, 2010). Additionally, treatments
like kava may cause harmful side effects, such as severe liver damage (National Center
for Complementary and Alternative Medicine, 2012). Amidst these findings, recent
attention has been drawn to the use of tea and its amino acid L-theanine for the
enhancement of relaxation (Vuong, Bowyer, & Roach, 2011). The rest of this review
will examine tea composition and consumption, as well as human studies of its effect on
anxiety.
Tea Varieties, Consumption, and Health Impacts
Since 1700 BC, tea has been perceived as a necessary substance for the
maintenance of health (Heiss & Heiss, 2007). Deemed the “elixir of life,” tea has
universally played a role in cultural, religious, social, and medicinal situations. Today,
tea is still recognized for its herbal-healing traditions and continues to thrive as one of
the world’s favorite beverages (Heiss & Heiss, 2007).
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Tea Varieties
All teas originate from the Camellia sinensis plant (Matthews, 2010).
Differences in processing methods produce the independent varieties of tea (Carlson,
Bauer, Vincent, Limburg, & Wilson, 2007). The four predominant types include green,
white, black and oolong (Matthews, 2010). In order to make green tea, bush leaves are
immediately steamed and dried after picking, which prevents oxidation and produces
larger amounts of catechins. Although green tea is recognized as having a simpler
flavor, thousands of varieties and flavors exist (Matthews, 2010). Similar to green tea,
white tea is unfermented. It is restricted from the sun in order to maintain its white hue
and pure taste (Alcázar et al., 2007).
Unlike green and white tea, black and oolong teas are fermented. In black tea
bush leaves are picked, withered, and crushed to promote oxidization (Heiss & Heiss,
2007). The high amounts of theaflavins and thearubigins found in black tea produce its
dark, rich color and flavor (Yang, Chen, & Wu, 2014). Oolong teas are much more
difficult to create since the leaves have specific size and sunlight requirements (Carlson
et al., 2007). After its leaves are prematurely plucked, they are crushed and
semioxidized. Consequently, they have a chemical combination like green and black
teas (Carlson et al., 2007) and produce a variety of rich and fruity aromas (Heiss &
Heiss, 2007).
Consumption Data and Consumer Trends
Worldwide. Every year, individuals consume an average of 40 liters of tea
(Alcázar et al., 2007), contributing to the annual worldwide production of almost 4.7
million tons (Statista, 2014). As one of the top consumers in tea, China is responsible for
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40% of worldwide tea production (Statista, 2014). Per capita, Ireland and Britain have
the greatest number of tea drinkers (Richardson, 2010). In all countries besides Asia,
black tea is the most frequently consumed tea type (Bryan, 2008). In response to this
popular demand, 75% of all tea produced is black tea (Carlson et al., 2007).
United States. Over half, or around 158 million Americans, drink tea daily (Tea
Association of the USA, 2013). An average American will drink almost 9 gallons of tea
each year (Statista, 2014), with 85% of it being iced. Retail markets annually sell about
$2.25 billion dollars worth of tea, with sales increasing nearly 16% within the past 5
years (Tea Association of the USA, 2013). Although black tea is at 84% of all tea sales,
green tea has been growing in popularity (Tea Association of the USA, 2013).
Continuous growth of this industry from all areas is expected, primarily due to the
highly publicized health benefits of tea (Bryan, 2008).
Proposed Health Effects
Due to the increasing interest of tea’s benefits, health effects have recently been
widely studied. Most studies have involved green tea (Yang et al., 2014). Due to its antiinflammatory activity, tea has been proposed to reduce cancer, high blood pressure, gum
disease, diabetes (Matthews, 2010), obesity, and metabolic syndrome (Yang et al.,
2014). More than half of randomized controlled trials involving tea have reported a
reduction in cardiovascular disease (Kuriyama, 2008). Additionally, a strong inverse
association has been observed for tea with stroke mortality (Kuriyama, 2008). Tea may
also have neuroprotective effects, potentially reducing the risk of Parkinson’s,
Huntington’s, and Alzheimer’s diseases (Yang et al., 2014). Although health effects may
be promising, the exact mechanism behind tea’s protection remains obscure (Kuriyama,
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2008). Several bioactive compounds are considered to contribute to tea’s suggested
health effects.
Bioactive Compounds
Tea has a variety of compounds that influence its flavor, mouthfeel, and
nutritional value (Heiss & Heiss, 2007). For example, a variety of vitamins and minerals
are naturally found in scant amounts within tea. Typical compounds include thiamine,
riboflavin, vitamin C, and fluoride (Heiss & Heiss, 2007). Better character ized
constituents include those discussed below.
Polyphenols. There is a variety of polyphenols found within tea that are proposed
to reduce levels of oxidative stress. Common polyphenols include catechins and
flavonols (Heiss & Heiss, 2007). An example of a well-known catechin is
epigallocatechin-2-gallate (EGCG), an antioxidant that makes up almost half of the total
polyphenols within green tea (Matthews, 2010). EGCG is suggested to be an
anticarcinogenic molecule that modulates gene expression by inhibiting deleterious
enzymes, angiogenesis, and intracellular peroxides (Matthews, 2010). Flavonols include
tannins, which give tea its astringent characteristics (Heiss & Heiss, 2007). Tannins are
also suggested to reduce gastrointestinal discomfort (Matthews, 2010).
Caffeine. Contributing to tea’s bitter taste, caffeine is a natural component found
in green, black, oolong, and white tea varieties (Heiss & Heiss, 2007). Multiple factors,
such as brewing time and water temperature, affect a tea’s caffeine level. On average, an
8-ounce serving of tea on average has 40 mg of caffeine (Bryan, 2008), or about one
third the amount regularly found in coffee (Matthews, 2010). Caffeine amounts in
specific tea types will later be presented in this literature review and can be found in
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Table 1. Caffeine crosses the blood
blood-brain barrier within 30 minutes and may strengthen
alertness, concentration,, physical and cognitive ability
ability. Highest
hest levels of caffeine are
found within 30-120
120 minutes after ingestion (Bryan, 2008).
L-theanine. The tea constituent L
L-theanine may interact with some of caffeine’s
stimulatory effects. It is proposed to induce tranquility and psychological well-being
well
while maintaining high levels of alertness (Bryan, 2008). L-theanine
theanine is suggested to
counteract caffeine’s arousing effects by lowering the body’s central nervous system
sys
response (Bryan, 2008). For exa
example, caffeine artificially
ially raises serotonin and gammagamma
aminobutyric acid levels, which are neurotransmitters that may contribute to
o anxiety.
anxiety Ltheanine is suggested to modulate the amount of these chemicals and reduce the adverse,
anxious consequences of cognitive overstimulation (Bryan, 2008). At the same time,
time Ltheanine appears to increase an individual’s acute and chronic attention span by
enhancing speed of information processing and improving mental accuracy with
complex activities. It may also decrease mental inactivity and exhaustion (Bryan, 2008).
2008)
L-theanine’s structure is comparable to glutamic acid
acid, an excitatory
neurotransmitter. Figure 2 displays the chemical structure of L
L-theanine. Along with
regulating serotonin and gamma
gamma-aminobutyric levels, L-theanine
theanine may also contribute to

Figure 2. Chemical structure of L
L-theanine. From Yang et al., 2014.
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relaxation by down-regulating glutamic acid through antagonistic pathways (Bryan,
2008).
L-theanine is a non-protein amino acid restrictedly found in tea leaves (Heiss &
Heiss, 2007) and contributes to the sweet umami flavor found in tea (Alcázar et al.,
2007). L-theanine constitutes over half the total amount of amino acids in tea (Alcázar et
al., 2007). Generally, L-theanine constitutes around 1-2% of tea by weight, resulting in
about 25-60 mg of L-theanine per 200 mL tea serving (Bryan, 2008). L-theanine’s
amount varies according to tea manufacturing and cultivation processes (Yang et al.,
2014). For instance, higher amounts of L-theanine are found in a tea plant with lower
fermentation (Alcázar et al., 2007) and reduced sun exposure (Heiss & Heiss, 2007).
Table 1 depicts the different types of tea in relation to their L-theanine and caffeine
content. When analyzing L-theanine levels, 0.25 g dried tea leaves were combined with
10 mL of water at 80°C for 25 minutes (Alcázar et al., 2007). When analyzing caffeine
amounts, 0.1 g of dried tea leaves were combined with 20 mL of boiling water for 10
minutes (Sereshti & Samadi, 2014).
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Table 1. Typical caffeine and L-theanine contents in different tea types
Tea Type

L-theanine (mg/g)a

Caffeine (µg/mL)b

Green

1.62-3.37

120.5

Black

0.49-4.12

149.5

Oolong

0.49-4.12

145.2

White

5.3-33.37

165.8

a
b

L-theanine in milligrams per gram of dried tea. From Alcázar et al., 2007.
Caffeine in micrograms per milliliter of liquid tea. From Sereshti & Samadi, 2014.

L-theanine can cross the blood-brain barrier within 30 minutes and may
contribute to the production of alpha brain waves (Tea Association of the USA, 2013).
Alpha brain waves are associated with relaxation and calmness (Nobre, Rao, & Owen,
2008). The remainder of this paper will examine human studies of the effects of tea and
its constituent L-theanine on anxiety.
Human Studies of Tea and Anxiety
Cross-Sectional Studies
Few large-scale cross-sectional studies have examined the relationship between
tea drinking and anxiety disorder. However, Hozawa et al. (2009) completed one
extensive study in 2006. This study examined whether average green tea intake was
associated with lower levels of psychological distress in Ohsaki City, Japan. At 24.4%,
Japan has one of the lowest lifetime risks of mental health disorders. In comparison, the
United States has one of the highest risks, at over 55%. This information may suggest
that a part of the Japanese culture may be responsible for this drastic difference. Since
17

tea drinking is a more prevalent custom in Japan than the United States, it may be one
factor that is responsible for this observation (Hozawa et al., 2009).
Three different questionnaires were mailed to all 77,235 households living in
Ohsaki City (Hozawa et al., 2009). Exposures were measured through a food-frequency
questionnaire (FFQ). Although the main exposure assessed was green tea, the FFQ also
measured intake of a variety of foods, coffee, black and oolong tea. The FFQ tested for
validity with 3-day food records given on 4 different days. A 6-item KPDS measured
mental health distress, the main outcome. The questions focused on mental stability over
the past month. Additionally, a baseline survey gathered characteristics of participants,
including age, gender, lifestyle factors, history of diseases, and social activities. Four
different multivariate logistic regression analyses controlled for differences in baseline
characteristics. Since all pertinent data were completed by 42,093 individuals, they were
the only participants included in the analyses (Hozawa et al., 2009).
Results from the KPDS displayed that 6.6% of subjects exhibited psychological
distress (Hozawa et al., 2009). Without adjusting for any confounders, the highest
prevalence of psychological distress (8.4%) was found among those consuming the least
amount of green tea, or less than 1 cup. On the contrary, the lowest prevalence of
psychological distress (5.1%) was found among those consuming the most green tea, or
5 or more cups daily. Odds ratio data was presented among four models that adjusted for
different confounding variables. Even in the simplest and most complex adjusted model,
the protective relationship between tea and levels of psychological distress remained
significant, in which the confidence intervals did not contain the null. In relation to
drinking less than 1 cup of green tea a day for the most fully adjusted model, the odds
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ratio of psychological distress for drinking 5 or more cups of green tea a day compared
to less than 1 cup was 0.80 (0.70, 0.91). However, with further addition of confounders
to each of the four models, relationships were mediated and attribution due to tea was
less. Nonetheless, all models suggested a dose response relationship, with p values for
trend < 0.001 (Hozawa et al., 2009). This supports that a higher green intake was
associated with a lower prevalence of psychological distress.
Hozawa et al. (2009) hypothesized that green tea consumption would be
associated with a lower risk of psychiatric stress. Their findings support their hypothesis,
in that all odds ratios revealed that higher amounts of green tea intake were significantly
associated with lower likelihood of psychological distress. Hozawa et al. (2009) limited
variability and erroneous results by using a large sample population and a significant
amount of individuals in each level of tea intake.
Although the Hozawa et al. (2009) study had statistically significant findings,
results are still not applicable to the general population. This study only included
individuals that were 40 years or older living in Japan. Cultural, habitual, and economic
factors are some of the few differences that separate Japan with other individuals
worldwide. Additionally, this study was mainly restricted to green tea. The few results
given for black tea were insignificant, with confidence intervals containing the null.
Although this study tested the validity of the food frequency questionnaire with a 3-day
food record, only 113 subjects completed the food records. The food records also
revealed that the reliability of the FFQ reliability was low (0.63-0.71). This suggests that
self-reporting is prone to human error and are not completely reliable.
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Compared to Hozawa et al. (2009), the Bryan et al. (2012) study focused on
individuals in a somewhat stressful, mentally-challenging occupational environment
(Bryan et al., 2012). Although Bryan et al. (2012) assessed many exposures and
outcomes, this literature review will focus on the intake of tea and its effect on mood
assessed with the Bond-Lader VAS relaxation subscale. One hundred and forty-two
volunteers were interested in this experiment, however individuals were excluded if they
did not complete all necessary information, disclosed burnout, or reported work abuse
within the past 6 months. Thus, 95 professional academic and administrative staff
members from three different South Australian colleges were included in the study
(Bryan et al., 2012). Besides a few descriptive characteristics, other baseline information
regarding the subjects was not given.
Exposures were measured through beverage diaries that assessed habitual intake
of tea (Bryan et al., 2012). The diaries also took into consideration the preparation style
and accompaniments of milk and sugar, along with other beverages including coffee,
other caffeinated drinks, and non-caffeinated drinks. Non-caffeinated beverages
included various hot beverages, juices, sodas, alcohol, and herbal teas. Although other
outcomes were recorded, including various work performance factors, tiredness, selfawareness, commitment to work, work-related stress and rehabilitation, this literature
review will mainly focus on the outcome of self-reported mood with the VAS relaxation
subscale. The Bond-Lader VAS was earlier described in this literature review. Bryan et
al. (2012) used a subscale that specifically measures calmness, with lower scores
associated with improved relaxation. Beverage diaries and self-reported mood were
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taken 4 times a day for 10 working days: prior to work, during the middle of work, after
work, and prior to sleeping (Bryan et al., 2012).
Since subjects provided data on different days, analyses were completed through
multilevel modeling. Bryan et al. (2012) assessed the direct association of beverage
exposure on calmness, as well as whether there was an association or interaction of
adding milk and sugar to tea. Results were displayed as separate data points between and
across hierarchical structures. The three levels of analysis included the time-frame, day,
and subject. The data were adjusted to eliminate daily variations and incidental trends
among participants. Although missing data points were infrequent, the data points were
recovered by spontaneously inputting numerical values, substituting average numbers,
or classifying the data as missing data points (Bryan et al., 2012). The study does not
mention why it would chose one option over the other, which could lead to inconsistent
recovery of data.
Within the 10 days reported, 64 subjects drank tea, with daily intakes ranging
from 0-7.5 cups, with the median being 1 cup (Bryan et al., 2012). Tea was associated
with a higher perception of work accomplishment, lower fatigue, alleviation of adverse
consequences of nighttime rehabilitation, and enhancement of morning mindfulness (p <
0.1). However, tea consumption was not associated with enhanced relaxation. Even
when adjusting for the addition of milk or sugar, effects of tea on relaxation were still
insignificant. The only significant relationship found with relaxation was a positive
relation among non-caffeinated beverages (p < 0.01), but not tea specifically (Bryan et
al., 2012). Although herbal teas were a subcategory of non-caffeinated beverages, this
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study did not provide results specific to herbal teas. Results could have been more
comprehensive if they individually measured herbal tea and its effect on relaxation.
In this observational experiment, tea and its association with relaxation were
uniquely studied within a common workplace environment. Therefore, Bryan et al.’s
(2012) results extended outside of a typical laboratory setting. By adjusting data, Bryan
et al. (2012) limited daily variations and supported a high internal validity. Unlike
Hozawa et al. (2009), Bryan et al. (2012) considered additives to tea, reflecting different
ways tea could be consumed. However, the multiple comparisons of many exposures
and outcomes gave a high opportunity for spurious relationships, making it difficult to
determine if a significant finding is real or a statistical anomaly.
The Bryan et al. (2012) study has several limitations. Bryan et al. (2012) pulled
information out of context in order to support their hypothesis. They hypothesized that
tea, when compared to other beverages, would have beneficial effects on work related
factors, including relaxation. This study did not fully discuss that tea did not contribute
to relaxation. Only significant relationships were reported; insignificant data were
ignored. Additionally, findings supported that the absence of caffeine encouraged
daytime relaxation. Since tea often contains caffeine, this finding may provide counterevidence for tea enhancing relaxation.
Since the sample population was very distinct and small, Bryan et al.’s (2012)
findings cannot be extended to the general population. Only a few subject characteristics
were given: most participants rated themselves with good health (4.08 on a scale of 1-5),
were female (78.9%), and were from a specific work environment and region (academic
and administrative staff in South Australia). Unlike Hozawa et al. (2009), Bryan et al.
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(2012) did not adjust for any differences in characteristics. Confounding factors could
have influenced any of the correlations that were given.
Table 2 compares the two recently discussed cross-sectional studies. Hozawa et
al. (2009) found that subjects who green drank tea were less likely to have psychological
distress, however Bryan et al. (2012) did not find a significant relationship between
intake of tea and relaxation. Although there are a limited number of studies in this
comparison, this table shows that there is an inconsistent relationship between tea and its
proposed anxiolytic effects.
Table 2. A summary of two cross-sectional studies examining the relationship between
consumption of tea and anxiety
Study
Subjects
Treatment
Outcome
Findings
Measure
Hozawa et
al., 2009

42,093 volunteers
40+ years living
in Ohsaki City,
Japan

Average cups of
green, black, and
oolong tea with
one FFQ

Prevalence of
psychological
distress using K6a at same time of
treatment

• Lowest prevalence of
psychological distress
among those consuming
the most amount of
green tea
• Odds ratios revealed
that higher intake of
green tea was associated
with lower prevalence
of psychological distress
with a dose response
relationship
• No significant findings
with black tea

Bryan et al.,
2012

95 South
Australian
academic
employees with
an average age of
37

Average habitual
intake of tea
including milk
and sugar
additives 4x day
for 10 days

Level of
relaxation with
VASb calmness
subscale at same
time of treatment

• Tea consumption not
associated with
enhanced relaxation
• Non-caffeinated
beverages positively
associated with
relaxation

a

K-6: Six question Likert scale test from the Kessler Psychological Distress Scale that measures levels
of psychological distress.
b
VAS: Visual analogue scales that measure subjective anxiety through a series of 100 mm scales.
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The inherent design of cross-sectional studies limit their findings. It cannot be
interpreted whether the exposure (tea) led to the outcome (lower psychological distress),
or vice versa. In order to make any definite conclusions, it is necessary to examine
clinical studies involving tea and anxiety. Only one has been published to date.
Clinical Study
An experiment by Steptoe et al. (2007) explored whether 6 weeks of black tea
intake would influence subjective responses toward acute stress. Although Steptoe et al.
(2007) considered objective measurements including cardiovascular, platelet, and
cortisol levels, this evaluation will mainly focus on the subjective stress and relaxation
ratings as the primary outcomes. In this double-blind experiment, 105 volunteers were
recruited by means of email and print. Subjects had to be healthy, nonsmoking, teadrinking men that were between 18-55 years old. Participants were excluded if they had
a previous psychiatric or medical history, were taking prescription medications, or
followed any diet. After a preliminary lab evaluation, subjects underwent a 4-week
washout period where all participants were restricted from caffeinated beverages, tea,
coffee, painkillers, nutritional supplements, and flavonoid rich foods. During this time,
all subjects were instructed to drink a placebo in the form of a fruit-flavored tea. The
washout period allowed for greater reliability of dietary adherence. Participants were
tested for adherence with self-report and saliva samples at the end of the washout period;
13 individuals did not follow the dietary instructions and were dropped from the study
(Steptoe et al., 2007).
After omitting 17 other participants due to inadequate data, 75 subjects were left
eligible for the study (Steptoe et al., 2007). Baseline characteristics were taken, which
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included habitual tea intake, race, age, educational degree, marital status, previous
smoker, and physical activity levels. Participants were then randomized into the
treatment or control group. Primarily as a result of randomization, subjects did not differ
in any measured baseline characteristics. Thirty-seven subjects were assigned to the
active treatment: a fruit-flavored, powdered black tea added to hot water 4 times daily.
Since the treatment group was unaware they were drinking tea, confounding variables
associated with drinking tea were likely eliminated. Thirty-eight subjects drank the
placebo: a fruit-flavored, tea-colored powder dissolved in hot water 4 times daily. The
experimental and control beverages had identical organoleptic qualities. Both treatments
also had equal amounts of caffeine, so the two conditions only differed in other tea
constituents (Steptoe et al., 2007).
Both groups followed their designated treatment for 6 weeks (Steptoe et al.,
2007). Compliance was tested for with self-report and caffeine saliva samples. Subjects
were instructed to consume one beverage before testing for outcomes. Prior to and after
the 6-week dietary intervention, subjects’ stress and relaxation levels were tested with 7point Likert scales. The scales measured perception of stress from low (1) to high stress
(7). Subjective measures were completed before (baseline), during, and 30 minutes after
assigning two behaviorally difficult activities. The activities included a stressful speech
challenge and a laborious mirror-tracing task. Although not described in detail in this
review, objective measurements were obtained prior to the subjective tests (Steptoe et
al., 2007).
During the span of recovery from baseline to post-stress recovery, the
experimental tea group had a significantly greater sense of relaxation (+6.36%), whereas

25

the control group had a reduced sense of relaxation (-3.19%) (p = 0.032) (Steptoe et al.,
2007). Combined, this difference in relaxation is nearly 10%. However, when analyzing
average subjective stress ratings after adjusti
adjusting for pretreatment responses, differences
between the two groups were insignificant (Steptoe et al., 2007). This finding
ing is depicted
in figure 3, where the solid line depicts the experimental tea group and the dashed line
represents the control group,, with groups nearly indistinguishable
indistinguishable.

Figure 3. Average subjective stress ratings (1=low stress, 7=high
stress) adjusted for pretreatment responses after 6 weeks of treatment.
Solid line is tea,
a, dashed line placebo. Responses include baseline,
speech task, mirror tracing (MT), and recovery trial. From Steptoe et
al., 2007.

The Steptoe et al. (2007) experiment has several strengths.. This study was
double-blinded,
blinded, limiting bias. Steptoe and his colleagues openly admitted that their first
hypothesis was not supported
supported—that
that tea would lower cardiovascular and platelet stress
responses. Another
nother strength is that this study provided a 6-week
week intervention period.
Many clinical trials obtain results after just one trial, however Steptoe et al. (2007) had a
long-run experiment that allowed for the development of substance response patterns.
patterns
Additionally, most of the results for task responses were logical and according to
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expectations: subjects correspondingly had greater acute stress ratings as a result of the
behavioral challenging tasks. Accordingly, all ratings of stress were lowered during
post-stress recovery. There was also no disparity in perception of task difficulty between
groups. Subjective post-relaxation results were supported and consistent with objective
outcomes. For example, lower subjective relaxation ratings were directly correlated with
lower levels of cortisol, a hormone associated with stress response (Steptoe et al., 2007).
However, not all of Steptoe et al.’s (2007) conclusions are fully substantiated or
sensible. Although Steptoe et al.’s study (2007) supported that tea improved relaxation,
they did not support that tea had protected against subjective stress. Since relaxation and
stress are opposing concepts, it would be assumed that findings between the two would
be in agreement. The Steptoe et al. (2007) experiment has some additional
shortcomings. Subjects were healthy, tea-drinking, middle-aged men. Since this is a
narrow population subgroup, results cannot be compared to the general society.
Additionally, results cannot be extended to other living conditions, such as a stress-free
environment. Findings only pertain to a condition involving a stressful situation within a
laboratory facility. Also, only one subjective test measured stress and relaxation posttreatment. Validity would have been further improved if additional tests during the
intervention measured outcomes. Besides caffeine, adherence to dietary constraints was
only assessed through self-report during the two tests. Results could have also been
more valid if objective quantifiers verified beverage compliance throughout the
intervention.
Steptoe et al. (2007) claim that tea may strengthen psychophysiological response
post-stress. They do not provide a proven mechanism behind their reasoning, but do
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allude to certain constituents within tea, including L-theanine, which may be responsible
for stress reduction. Clinical trials involving L-theanine and its effect on anxiety will
now be discussed.
Clinical Studies of L-theanine and Anxiety
Human trials of L-theanine and anxiety have been conducted using different
outcomes measures, including self-report anxiety questionnaires and changes in alpha
brain waves. This next section will discuss experiments that have measured anxiety
either subjectively or objectively.
Measurements using anxiety questionnaires. A double-blind, randomized study
by Haskell and his colleagues compared the acute effects of L-theanine and caffeine
together and individually on psychological measures of mood (Haskell, Kennedy, Milne,
Wesnes, & Scholey, 2008). Although this study measured other factors including
reaction time, memory accuracy, and word recognition, this literature review will focus
on the outcome of relaxation measured by the Bond-Lader VAS. Nine males and 15
females from ages 18-34 years volunteered for this study. Participants were
undergraduate students in good health and free from drugs, medications, and smoking.
Subjects were required to restrict themselves from caffeinated and alcoholic beverages
during and for at least 12 hours before testing (Haskell et al., 2008).
This balanced crossover study used 250 mg L-theanine, 150 mg caffeine, 250 mg
L-theanine and 150 mg caffeine combined, and a placebo containing neither component
as exposures in a 250 mL Lipton Iced Tea drink (Haskell et al., 2008). The drink tasted
similar between the placebo and treatment groups. The Bond-Lader’s calm, content, and
alert subscales measured changes in subject anxiety. Details about this scale were earlier
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described in this paper.. Outcomes were measured 5 times 7 days apart at baseline, 30
minutes post-dose,
dose, and 90 minutes post
post-dose (Haskell et al., 2008). The multiple
ultiple days of
nonconsecutive testing improved reliability and decreased results due to chance.
Statistical analyses were co
completed through ANOVA (Haskell et al., 2008).
2008)
Paired t-tests compared the three conditions to the placebo. There was a significant
positive effect of L-theanine
theanine plus caffeine versus the placebo on the Bond-Lader
Lader alert
subscale (p < 0.01),, as shown in F
Figure 4. There were no other significant effects on
anxiety with L-theanine
theanine in isolation and L
L-theanine taken with caffeine (Haskell et al.,
2008).

Figure 4. Average baseline change (mm) in the Bond-Lader’s subscale of alert with
placebo, 150 mg caffeine, 250 mg L
L-theanine,
theanine, and a combination of 150 mg caffeine
and 250 mg L-theanine.
theanine. More positive values indicate higher positive ratings (p < 0.01).
From Haskell et al., 2008.

(2007), Haskell et al. (2008) considered the confounding
Like Steptoe et al. (2007)
variable caffeine within their analysis. Since caffeine is commonly found within tea, it is
important to consider the effects of both exposures taken together. Subjects were tested
for their adherence to caffeine intake with saliva samples.. Higher levels of caffeine were
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accordingly found in the caffeine and in the combined caffeine and L-theanine
treatments (p < 0.0001) (Haskell et al., 2008).
Although Haskell et al. (2008) found a significant effect of L-theanine and
caffeine on alertness, caffeine in isolation also improved factors of cognitive ability.
This may suggest that caffeine, not L-theanine, could be the primary contributor to the
effect on alertness. It is also important to note the potential side effects when
supplementing with L-theanine. Compared to the other treatment conditions, subjects
who took the isolated form of L-theanine had impairment with an attention span activity
and also had elevated reports of headaches (p < 0.05) (Haskell et al., 2008). It is also
critical to consider that the given levels of L-theanine (250 mg) and caffeine (150 mg) in
this experiment are much greater than what are found in a typical tea bag. Haskell et al.
(2008) would need to examine the effects of L-theanine and caffeine at more realistic
dietary levels (50 mg, 40 mg) in order to extend any findings to tea.
In another clinical trial with crossover design, Lu et al. (2004) compared Ltheanine’s acute effects on anxiety to a placebo and positive control, alprazolam (Lu et
al., 2004). Outcomes of anxiety were measured before and after treatment administration
with the BAI, VAMS, and STAI. In this study, 12 males and four females ages 18-34
were found through University announcements. Subjects were screened and interviewed
for the following requirements: subjects had to be non-smokers, healthy, could not have
any individual or ancestral history of psychological disorders, and could not be taking
any medication. Treatments included 200 mg of L-theanine as the supplemental form
Suntheanine, 1 mg of alprazolam as the commercial brand Xanax, and a placebo pill. All
participants were given each treatment 3 times on separate days, with at least 7 days in
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between testing. In an effort to account for metabolism disparities, participants were told
to consume a similar breakfast the day of treatment, to not drink caffeine or alcohol 24
hours before testing, and were given a standard meal 3.5 hours after their designated
treatment. In an attempt to control for variations in mood due to a woman’s menstrual
cycle, females were only tested during their follicular phase (Lu et al., 2004). These
procedures improved consistency among subjects.
After giving subjects their treatments, this double-blind, repeated measure
experiment assessed behavioral anxiety in two task conditions: a state of relaxation and
a state of experimentally induced anticipatory anxiety (Lu et al., 2004). Anticipatory
anxiety is a common response to stressful, critical situations and can be elicited by
electrical shocks. The experimental condition asked subjects to focus on their feelings
while staring at a computer screen. When a red border framed the screen, participants in
the experimentally induced anxiety group were informed they would randomly receive
electrical stimulation to their right hand. Contrary, the participants in the relaxed
condition were correctly told they would not receive the electrical shocks and had a blue
border frame their computer screen. The colored stimulus appeared for a total of 180
seconds within each 5-hour experiment (Lu et al., 2004).
Anxiety was measured with the BAI, VAMS, and STAI 1 hour before treatment,
2.5 and 5 hours post-treatment (Lu et al., 2004). The BAI, VAMS, and STAI are all selfreported subjective questionnaires that were previously discussed in this literature
review. All of the questionnaires were all-inclusive besides the VAMS. The VAMS only
focused on three of its eight different mood subscales: calm-excited, relaxed-tense, and
tranquil-troubled. Average treatment scores with respect to time were calculated and
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compared to baseline values. Scores were analyzed with multivariate analysis of
variance and task conditions were compared with a paired-sample t-test. Subjects were
also monitored for any changes in physiological symptoms (Lu et al., 2004).
Scores for the tranquil-troubled subscale of the VAMS showed that L-theanine
had slight calming effects when compared to alprazolam or a placebo during subjects’
relaxed states (p = 0.03) (Lu et al., 2004). However, L-theanine had insignificant effects
for all of the remaining questionnaires in both task conditions. With only one subscale
having a significant relationship, effects of L-theanine on anxiety may be considered
weak. However, Lu et al. (2004) still argued that their experiment provided evidence
that L-theanine has calming effects when an individual is in a state of relaxation.
Unlike Steptoe et al. (2007) who mostly reported logical subjective and objective
outcomes in their study involving black tea intake on acute levels of stress, Lu et al.
(2004) had multiple controversial issues when analyzing their results. As a prescription
drug designed for the relief of anxiety, alprazolam was the experiment’s positive
control—it was expected to reduce subjective anxiety scores. Contrary to expectations,
alprazolam didn’t have any calming effects for any of the questionnaires in the relaxed
or anxiety-induced state when compared to the placebo. In fact, alprazolam actually
heightened STAI anxiety scores when compared to the placebo in the relaxed condition.
These paradoxical results may lessen the validity of the experiment’s findings with Ltheanine. If the subjective measures were too insensitive to detect alprazolam’s effects
on anxiety, it may also be too insensitive to detect L-theanine’s effect on anxiety.
Further questions emerge when analyzing the findings. The anxiety-induced
condition was designed to elevate anxiety. However, when compared to the relaxed
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condition, average anxiety scores were only heightened in the BAI and the tranquiltroubled subscale of the VAMS (p < .05) (Lu et al., 2004). The other subjective tests did
not show any differences between the relaxed and anxiety-induced condition. Outcomes
with their conditions contrast with Steptoe et al. (2007), where subjects appropriately
had greater average stress ratings from the behavioral challenging tasks. Lu et al. (2004)
tried to rationalize the insignificant effects seen with L-theanine and alprazolam,
suggesting that results were insignificant because the experimentally induced anxiety
level was too strong. However, if this were true, then the analyses should have shown
that anxiety was heightened during the anticipatory anxiety state. As previously
mentioned, the majority of their results did not confirm this.
Although Lu et al. (2004) used a positive control and three reputable tests to
measure outcomes, most of their results were conflicting. Lu et al. (2004) only focused
on the positive findings to support their hypothesis: that alprazolam and L-theanine
would reduce subjective anxiety. The Lu et al. (2004) study also had a low sample of 16
subjects. Participants were educated, young adults in a laboratory setting, and findings
cannot be generalized to a natural environment. Study results also cannot be compared
to the amount of L-theanine found in tea. Like Haskell et al. (2008) who used 250 mg of
L-theanine as the treatment, Lu et al. (2004) also used a dose of L-theanine (200 mg)
that is much greater than the average cup of tea (50 mg). Additionally, although Lu et al.
(2004) mentioned that outcome measurements taken at 2.5 and 5 hours post-treatment
coincided with peak pharmacokinetic effects of L-theanine, L-theanine is suggested in
the literature to have effects within half an hour (Tea Association of the USA, 2013).
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The analysis may have been more thorough if it included the immediate effects of Ltheanine on anxiety.
Measurement of alpha-brain waves. A few studies have relied on using
electroencephalography (EEG) to examine L-theanine’s effect on alpha brain waves. As
previously mentioned, a higher proportion of alpha brain waves are associated with a
state of relaxation. If L-theanine enhances brain wave activity, it may be identified as the
constituent responsible for calmness.
Juneja and his colleagues were some of the first individuals who studied the
effects of L-theanine on alpha brain waves. Outcomes of alpha wave production were
measured on the parietal and occipital brain areas (Juneja, Chu, Okubo, Nagato, &
Yokogoshi, 1999). Although this study is highly referenced in subsequent papers
involving L-theanine and anxiety, it carries limited information because it is an
unpublished experiment within a review paper (Juneja et al., 1999). This author will
describe all pertinent information that Juneja et al. (1999) provided.
Eight subjects, ages 18-22 years, were selected from 50 female volunteers
(Juneja et al., 1999). The study does not mention how or why the subjects were chosen.
Participants were equally split into high- and low-anxiety groups based on results from
the Manifest Anxiety Scale (MAS). Specific information regarding treatments was
limited, however the study mentions that the treatment group switched off receiving 50
or 200 mg of Suntheanine, a commercial product for L-theanine. Suntheanine was
prepared by dissolving the prescribed dose in 100 mL of water, whereas the control
group only received water. Measurements were completed in 10-minute intervals from
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time of intake until 60 minutes with EEG topography. Measurements were recorded
twice a week for 2 months (Juneja et al., 1999).
Juneja et al. (1999) proposed that L-theanine, in doses of either 50 mg or 200
mg, would promote the generation of alpha waves (Juneja et al., 1999). After half an
hour, subjects who ingested the L-theanine solution had a significant, dose-dependent
enhancement of alpha brain waves compared to the control group. This finding is
supported by the proposition that L-theanine crosses the blood-brain barrier within half
an hour. The subjects produced the greatest amounts of alpha brain waves after 40
minutes of intake. Juneja et al. (1999) did not provide p-values or the specific
quantitative changes in brain wave intensities between the control and placebo groups.
Additionally, Juneja et al. (1999) did not describe the differences in brain waves
between the 50 mg or 200 mg doses of L-theanine. Results between the high- and lowanxiety subjects also were not compared.
Although Juenja et al. (1999) depicted images of both alpha-1 and alpha-2 brain
waves, alpha-1 brain waves are the only alpha subtype associated with a state of
relaxation (Niedermeyer, 1997). Thus, only alpha-1 waves will be examined here.
Figure 5 depicts the results of alpha-1 wave topographies from an EEG comparing the
treatment and placebo groups (Juneja et al., 1999). This study did not describe if this
image depicts the average scan of all individuals. This study also does not note if the
subjects were relaxed or mentally aroused while receiving the brain scans. In this figure,
a darker color (black) is associated with stronger brain waves. After 30 minutes, alpha
waves appear to be greater in the L-theanine group compared to the placebo, which is
consistent with the study’s proposed results. Alpha brain waves appear to be stronger for
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water at 20 minutes than at other time periods; Juneja et al. (1999) do not provide
reasoning for why this may occur.

Figure 5. Alpha wave production shown in 10-minute intervals after intake of either water or
L-theanine in volunteers. Topographies are from EEG data. From Juneja et al., 1999.

Although results showed a positive effect of L-theanine on alpha brain waves,
multiple limitations of this study need to be considered. Four authors in the Juneja et al.
(1999) review are in a company that makes Suntheanine. Since the authors repeatedly
promote the sale of Suntheanine, authors have a recognizable conflict of interest. Their
biased position leads them to jump to the conclusion that Suntheanine effectively
improves relaxation. As previously mentioned, this study comes from a review paper
and its data were not individually published or peer reviewed. This can contribute to
biased results and also limits available information that is necessary for analyzing the
credibility of the study. Since this study does not mention that it was double-blinded or
randomized, it could have had a biased sample selection and distribution. Without
proper randomization, results could have been attributed to confounders. Baseline
characteristics were not considered or adjusted for in the analysis. Additionally, the
small sample size increases likelihood of spurious results.
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Compared to Juneja et al. (1999) who used 50 and 200 mg of L-theanine as their
exposure, Nobre et al. (2008) solely gave 50 mg doses of L-theanine to the treatment
group. Nobre et al. (2008) examined alpha brain wave measurements in relation to time
as the primary outcome. Sixteen young, healthy volunteers were given 50 mg of
powdered L-theanine mixed in a tea beverage. Nineteen participants in the control group
were given 100 mL of chilled drinking water (Nobre et al., 2008). Baseline
characteristics about the subject were not studied.
During the outcome measurement, participants were watching television and
under a relaxed, alert mentality (Nobre et al., 2008). Nobre et al. (2008) used EEG’s to
examine the changes in alpha brain waves at 45, 60, 75, 90, and 105 minutes after the
tea or water treatment. In the experimental group, alpha brain waves significantly
increased in linear correlation with elapsed time (p < 0.05) (Nobre et al., 2008). Figure 6
displays the average alpha brain wave activity over time. In this figure, brain waves are
measured in microVolts2 and greater amount of alpha brain waves are associated with a
red-orange hue. Clearly, the L-theanine group appears to have a greater average
production of alpha waves.
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Figure 6. Average power of alpha brain waves ((microVolts²) over time (minutes) after
consumption of water or 50 mg L
L-theanine beverage. From Nobre et al., 2008.

At all time intervals,, alpha intensity appears to be significantly greater in the
group consuming L-theanine
theanine compared to the control. These results support that LL
theanine may affect the central nervous system and enhance relaxation (Nobre et al.,
2008). When compared to the Juneja et al. (1999) study, the Nobre et al. (2008) study
was much more descriptive in experiment specifications. For instance, they noted
specifics involving the selection of subjects and included the quantitative measurements
meas
of alpha bands. This study also had a larger sample size (35 subjects) than the Juneja et
al. (1999) experiment (8 subjects)
subjects), improving the applicability of findings. Compared to
Juneja et al. (1999) who used 50 and 200 mg of L
L-theanine, Nobre et al. (2008) also
used more consistent, realistic dietary amounts of L
L-theanine (50 mg).
The Nobre et al. (2008) study did have distinct limitations, similar to the Juneja
et al. (1999) study. The authors are affiliated with the sale of L-theanine
theanine products. This
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may lead to publication bias, limiting findings. Also, these experiments were not
randomized or double-blinded, and baseline characteristics were not assessed or adjusted
for. Nobre et al. (2008) did not assess anxiety levels in patients, yet differences in
anxiety levels among subjects could be a major confounding variable. Whereas Juneja et
al. (1999) measured outcomes twice a week for a period of 2 months, Nobre et al. (2008)
only measured outcomes once.
The five clinical studies that were analyzed in this literature review are
summarized in Table 3. Although the findings support that tea and L-theanine have
significant anxiolytic effects, it is important to consider each study’s limitations. Juneja
et al. (1999) and Nobre et al. (2008) were parallel-arm trials that lacked randomization
and were not double-blinded. Other limitations include publication bias and the lack of
adjustment for confounders. As a result, they may be considered as studies of
insufficient quality to confirm a meaningful relationship between L-theanine and
anxiety. Stronger studies included Steptoe et al. (2007), Haskell et al. (2008), and Lu et
al. (2004). All studies in this group were double-blinded, and Steptoe et al (2007) and
Haskell et al. (2008) were randomized studies. The Steptoe et al. (2007) study was
parallel-arm, whereas Haskell et al. (2008) and Lu et al. (2004) were experiments with a
crossover design. Although these studies had their individual limitations, including small
sample sizes and acute doses of L-theanine that are too high to be relatable to a single
serving of tea, they are higher quality studies.
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Table 3. A summary of five clinical studies examining the effect of tea and its constituent L-theanine on anxiety

Study and
design

Subjects

Treatment

Outcome Measurea

Findings

Steptoe et al.,
2007; parallelarm

75 healthy, teadrinking men
ages 18-55

Fruit-flavored black tea
vs fruit-flavored
beverage taken 4x/day
for 6 weeks

Subjective measurement of stress
and relaxation during behavioral
challenging tasks with 7-point
Likert scales taken pre- and posttreatment

Haskell et al.,
2008; crossover

24 healthy
undergraduate
students ages
18-34

250 mg L-theanine, 250
mg L-theanine & 150
mg caffeine vs. neither
components in 250 mL
iced tea taken 5x 7 days
apart

Subjective measurement of anxiety • Caffeine & L-theanine together improved alertness 30
during cognitive tasks with Bond& 90 minutes post-dose
Lader VAS subscales alert, content • No significant relationships found between just Land calm. Measurements taken
theanine and outcome
prior, 30 & 90 minutes posttreatment

Lu et al., 2004;
crossover

16 healthy
students ages
18-34

200 mg L-theanine as
Suntheanine, 1 mg
alprazolam vs. placebo
pill taken
1x/week for 3 weeks

Subjective measurement of
behavioral anxiety in state of
relaxation and induced
anticipatory anxiety with VAMS,
BAI & STAI

Juneja et al., 1999;
parallel-arm

8 female
subjects ages of
unknown ages

50 mg, 200 mg Ltheanine as Suntheanine
in 100 mL water vs.
water. Unknown length
& interval of intake

Objective measurement of alpha
• L-theanine had dose-dependent enhancement of alpha
waves on unknown state with EEG brain waves vs. control after 30 minutes
2x/week for 2 months
• L-theanine had greatest amounts of alpha waves after
40 minutes of intake

Nobre et al., 2008;
parallel-arm

35 young,
healthy
volunteers of
unknown ages

50 mg powdered Ltheanine mixed in tea
beverage vs. 100 mL
water taken once

Objective measurement of alpha
• Alpha intensity greater in L-theanine group vs water
waves with EEG during relaxed
at all measured time intervals
state at 45, 60, 75, 90, 105 minutes
post-treatment

a

• Tea group had 9.54% greater sense of relaxation vs.
control amongst span of recovery
• Similar ratings of average subjective stress levels
when adjusting for pretreatment responses

• Only tranquil-troubled subscale of VAMS showed
slight calming effects

Outcome measure abbreviations:
VAS: Visual analogue scales. Measures subjective anxiety through a series of 100 mm scales.
VAMS: Visual analogue mood scales. Measures mood behavior through the marking of various statements or symbolic faces.
BAI: Beck Anxiety Inventory. Measures cognitive, subjective, and objective indicators of anxiety using a 4-point Likert scale.
STAI: State-Trait Anxiety Inventory. Measures state and trait anxiety through 4-point Likert scales.
EEG: Electroencephalography. Records electrical brain wave activity.
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Summary & Future Research Needs
This literature review assessed two cross-sectional and five clinical trials, all of
the available literature relevant to this topic. The two observational studies and first
clinical trial focused on the consumption of tea as the primary exposure and used
subjective measurements of stress as the primary outcome. The four remaining clinical
trials assessed tea’s constituent, L-theanine, as a potential relaxation treatment by using
subjective and objective outcome measurements. Despite the suggestion that tea and its
constituent L-theanine may provide anxiolytic effects, the seven studies evaluated in this
review provide contradictory evidence to support this claim. Although the studies
focused on similar subject matter, the studies are not truly comparable. The studies had
different types and lengths of exposures, methods of measurement, and outcomes.
Overall, however, the majority of studies had limitations that outweighed their strengths.
Most of the studies in this literature review had a small sample size involving
healthy, young adults as sample subjects. In order to extend findings to the general
population, larger sample sizes, different ages, ethnicities, educational levels, and
regions need to be considered. Testing in different environments also needs to be
performed. Experiments should include a non-stress control condition along with an
experimentally induced stress condition to examine the effects of social circumstances.
Additional intervening variables, including caffeine, need to be adequately recognized
and controlled for. Therefore, results can more likely be attributed to the designated
exposure.
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This author suggests that additional research is needed before forming any
definite conclusions involving tea and its constituent L-theanine on anxiety. Specifically,
more double-blinded, randomized controlled clinical trials that are crossover design
need to be performed. In order to form any significant conclusions, future studies need
to be undertaken using consistent exposures. This way, results from separate studies can
be more accurately compared. If a study uses L-theanine as an exposure, doses at
realistic dietary levels need to be prescribed. If a study uses tea as an exposure, studies
should involve all common tea types, so that the exposures can be relevant to the
standard tea-drinking population. It is also recommended that future studies give
exposures for longer periods of time. A chronic treatment may give a more accurate
understanding of how habitual intake of tea or L-theanine affects anxiety.
Future studies also need to include systematic measurements for assessing
exposures and outcomes. Tools need to be practical and validated. In order to obtain the
most accurate and comprehensive data from subjects, it would be beneficial for studies
to use both subjective and objective measurements during their assessments. Subjective
measurements, including self-reported questionnaires, elicit issues such as bias and
human error. Objective measurements, such as the measurement of alpha brain waves,
can be considered to be an indirect, crude measurement. When used together,
corresponding subjective and objective outcomes may help verify data.
One key research question that still remains unanswered is whether the effects of
L-theanine in isolation are truly comparable to L-theanine found in tea. Although Ltheanine can be provided as a pharmacological compound in higher amounts than what
is normally found in tea, this is irrelevant to the main focus of this literature review. The
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majority of studies used acute amounts of L-theanine much higher, or around 4-6 times
greater, than what is usually found in a single serving of tea. The mechanism and
bioavailability behind L-theanine is unknown. Thus, isolated L-theanine may have
different outcomes than when it is found in its holistic entity, tea. To make appropriate
comparisons, future studies need to focus on amounts of L-theanine that can be easily
achieved in an individual’s typical diet. If studies had significant protective findings
with L-theanine, the protective relationship could be more relatable to tea.
Due to anxiety’s high prevalence and co-morbidity, it is important to continue
research on this topic. The United States has a high prevalence of anxiety, yet all of the
studies in this review were either investigated or published from authors around the
globe. As seen, our scientific community has not given sufficient time and resources to
investigate this topic. Yet, current treatments for anxiety are expensive, addicting, carry
adverse side effects, and do not mitigate symptoms for everyone. Alternative methods,
including tea, may be promising. Tea is a low-cost beverage that is universally accepted,
does not have any serious side effects, and may have a variety of health benefits. With
the growing number of tea-drinkers and diagnoses of anxiety disorders, it is worthwhile
to determine whether there is a significant relationship between tea, its constituent Ltheanine, and anxiety.

43

References

Albert, C. M., Chae, C. U., Rexrode, K. M., Manson, J. E., & Kawachi, I. (2005). Phobic
anxiety and risk of coronary heart disease and sudden cardiac death among
women. Circulation, 111(4), 480–7.
doi:10.1161/01.CIR.0000153813.64165.5D
Alcázar, A., Ballesteros, O., Jurado, J. M., Pablos, F., Martín, M. J., Vilches, J. L., &
Navalón, A. (2007). Differentiation of green, white, black, Oolong, and Pu-erh
teas according to their free amino acids content. Journal of Agricultural and
Food Chemistry, 55(15), 5960–5. doi:10.1021/jf070601a
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of
Mental Disorders (5th ed.). Washington, DC.
American Psychological Association. (2014). The State-Trait Anxiety Inventory
(STAI). The State-Trait Anxiety Inventory (STAI). Retrieved October 19, 2014,
from http://www.apa.org/pi/about/publications/caregivers/practicesettings/assessment/tools/trait-state.aspx
Anxiety and Depression Association of America. (2014a). Chronic Pain. Retrieved
October 23, 2014, from http://www.adaa.org/understanding-anxiety/relatedillnesses/other-related-conditions/chronic-pain
Anxiety and Depression Association of America. (2014b). Eating Disorders.
Retrieved October 23, 2014, from http://www.adaa.org/understandinganxiety/related-illnesses/eating-disorders
Anxiety and Depression Association of America. (2014c). Therapy. Retrieved
October 23, 2014, from http://www.adaa.org/findinghelp/treatment/therapy
Barlow, D. H. (2004). Anxiety and Its Disorders: The Nature and Treatment of Anxiety
and Panic (p. 704). Guilford Press. Retrieved from
http://books.google.com/books?hl=en&lr=&id=Lx9hf-3ZJCQC&pgis=1
Baxter, A. J., Vos, T., Scott, K. M., Ferrari, A. J., & Whiteford, H. A. (2014). The global
burden of anxiety disorders in 2010. Psychological Medicine, 44(11), 1–12.
doi:10.1017/S0033291713003243
Beck, A., & Steer, R. (1990). Manual for the Beck Anxiety Inventory (pp. 1–5). San
Antonio: Hatcourt Brace and Company. Retrieved from
http://psycnet.apa.org/psycinfo/1997-09146-002

44

Bond, A., & Lader, M. (1974). The use of analogue scales in rating subjective
feelings. British Journal of Medical Psychology, 47(3), 211–218.
doi:10.1111/j.2044-8341.1974.tb02285.x
Bryan, J. (2008). Psychological effects of dietary components of tea: caffeine and Ltheanine. Nutrition Reviews, 66(2), 82–90. doi:10.1111/j.17534887.2007.00011.x
Bryan, J., Tuckey, M., Einöther, S. J. L., Garczarek, U., Garrick, A., & De Bruin, E. A.
(2012). Relationships between tea and other beverage consumption to work
performance and mood. Appetite, 58(1), 339–46.
doi:10.1016/j.appet.2011.11.009
Carlson, J., Bauer, B. A., Vincent, A., Limburg, P. K., & Wilson, T. (2007). Reading the
Tea Leaves: Anticarcinogenic Properties of (-)-Epigallocatechin-3-Gallate.
Mayo Clinic Proceedings, 82(6), 725–32.
Craske, M. G., Rauch, S. L., Ursano, R., Prenoveau, J., Pine, D. S., & Zinbarg, R. E.
(2009). What is an anxiety disorder? Depression and Anxiety, 26(12), 1066–85.
doi:10.1002/da.20633
Einöther, S. J., & Martens, V. E. (2013). Acute effects of tea consumption on
attention and mood. The American Journal of Clinical Nutrition, 98(6 Suppl),
1700S–1708S. doi:10.3945/ajcn.113.058248
Harvard Medical School. (2008). Anxiety and physical illness. Harvard Health
LPublications. Retrieved October 23, 2014, from
http://www.health.harvard.edu/newsletters/Harvard_Womens_Health_Watc
h/2008/July/Anxiety_and_physical_illness
Haskell, C. F., Kennedy, D. O., Milne, A. L., Wesnes, K. A., & Scholey, A. B. (2008). The
effects of L-theanine, caffeine and their combination on cognition and mood.
Biological Psychology, 77(2), 113–22. doi:10.1016/j.biopsycho.2007.09.008
Heiss, M. L., & Heiss, R. J. (2007). The Story of Tea: A Cultural History and Drinking
Guide (p. 417). Ten Speed Press. Retrieved from
http://books.google.com/books?id=3NBtM5aAAGgC&pgis=1
Hozawa, A., Kuriyama, S., Nakaya, N., Ohmori-Matsuda, K., Kakizaki, M., Sone, T., …
Tsuji, I. (2009). Green tea consumption is associated with lower psychological
distress in a general population: the Ohsaki Cohort 2006 Study. The American
Journal of Clinical Nutrition, 90(5), 1390–6. doi:10.3945/ajcn.2009.28214
Julian, L. J. (2011). Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck
Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety
45

(HADS-A). Arthritis Care & Research, 63 Suppl 1, S467–72.
doi:10.1002/acr.20561
Juneja, L., Chu, D., Okubo, T., Nagato, Y., & Yokogoshi, H. (1999). L-theanine—a
unique amino acid of green tea and its relaxation effect in humans. Trends in
Food Science & Technology, 10(6-7), 199–204. doi:10.1016/S09242244(99)00044-8
Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., … Wang, P.
S. (2009). The global burden of mental disorders: an update from the WHO
World Mental Health (WMH) surveys. Epidemiologia E Psichiatria Sociale,
18(1), 23–33. Retrieved from
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3039289&tool=
pmcentrez&rendertype=abstract
Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005).
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the
National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6),
617–27. doi:10.1001/archpsyc.62.6.617
Kessler RC, Barker PR, C., & LJ, Epstein JF, Gfroerer JC, Hiripi E, et al. (2003).
Screening for serious mental illness in the general population. Arch Gen
Psychiatry, 60(2), 184–9. Retrieved from
http://www.qcomp.com.au/media/29424/kessler-psychological-distressscale-k10[1].pdf
Kimura, K., Ozeki, M., Juneja, L. R., & Ohira, H. (2007). L-Theanine reduces
psychological and physiological stress responses. Biological Psychology, 74(1),
39–45. doi:10.1016/j.biopsycho.2006.06.006
Kuriyama, S. (2008). The Relation between Green Tea Consumption and
Cardiovascular Disease as Evidenced by Epidemiological Studies. J. Nutr.,
138(8), 1548S–1553. Retrieved from
http://jn.nutrition.org/content/138/8/1548S.long
Lakhan, S. E., & Vieira, K. F. (2010). Nutritional and herbal supplements for anxiety
and anxiety-related disorders: systematic review. Nutrition Journal, 9, 42.
doi:10.1186/1475-2891-9-42
Lu, K., Gray, M. A., Oliver, C., Liley, D. T., Harrison, B. J., Bartholomeusz, C. F., …
Nathan, P. J. (2004). The acute effects of L-theanine in comparison with
alprazolam on anticipatory anxiety in humans. Human Psychopharmacology,
19(7), 457–65. doi:10.1002/hup.611
Matthews, C. M. (2010). Steep your genes in health: drink tea. Proceedings (Baylor
University. Medical Center), 23(2), 142–4. Retrieved from
46

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2848091&tool=
pmcentrez&rendertype=abstract
McCallum, S. R. (2003). Handbook of Nonverbal Assessment (p. 390). Springer
Science & Business Media. Retrieved from
http://books.google.com/books?id=_Z_rgY-Qb-sC&pgis=1
National Center for Complementary and Alternative Medicine. (2012). Kava.
Retrieved November 06, 2014, from
http://nccam.nih.gov/sites/nccam.nih.gov/files/Herbs_At_A_Glance_Kava_0615-2012_0.pdf
National Institute of Health. (2014). Anxiety Disorders. Anxiety Disorders. Retrieved
October 23, 2014, from
http://nihseniorhealth.gov/anxietydisorders/riskfactorsandcauses/01.html
National Institute of Mental Health. (2005). Any Anxiety Disorder Among Adults.
Retrieved October 23, 2014, from
http://www.nimh.nih.gov/health/statistics/prevalence/any-anxiety-disorderamong-adults.shtml
National Institute of Mental Health. (2009). Anxiety Disorders. Anxiety Disorders.
Retrieved October 17, 2014, from
http://www.nimh.nih.gov/health/topics/anxiety-disorders/index.shtml
Niedermeyer, E. (1997). Alpha rhythms as physiological and abnormal phenomena.
International Journal of Psychophysiology : Official Journal of the International
Organization of Psychophysiology, 26(1-3), 31–49. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/9202993
Nobre, A. C., Rao, A., & Owen, G. N. (2008). L-theanine, a natural constituent in tea,
and its effect on mental state. Asia Pacific Journal of Clinical Nutrition, 17 Suppl
1, 167–8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18296328
Olatunji, B. O., Cisler, J. M., & Tolin, D. F. (2007). Quality of life in the anxiety
disorders: a meta-analytic review. Clinical Psychology Review, 27(5), 572–81.
doi:10.1016/j.cpr.2007.01.015
Richardson, L. B. (2010). The World in Your Teacup: Celebrating Tea Traditions,
Near and Far (pp. 1–72). Eugene: Harvest House Publishers.
Sereshti, H., & Samadi, S. (2014). A rapid and simple determination of caffeine in
teas, coffees and eight beverages. Food Chemistry, 158, 8–13.
doi:10.1016/j.foodchem.2014.02.095

47

Statista. (2014). U.S. Tea Market-Statistics & Facts. Retrieved from
http://www.statista.com/topics/1513/tea-market/
Steptoe, A., Gibson, E. L., Vuononvirta, R., Williams, E. D., Hamer, M., Rycroft, J. A., …
Wardle, J. (2007). The effects of tea on psychophysiological stress responsivity
and post-stress recovery: a randomised double-blind trial.
Psychopharmacology, 190(1), 81–9. doi:10.1007/s00213-006-0573-2
Stern, R.A., Arruda, J.E., Hooper, C.R. & Wolfner, G. (1997). Visual analogue mood
scales to measure internal mood state in neurologically impaired patients:
description and initial validity evidence. Aphasiology, 11, 59–71. Retrieved
from http://libres.uncg.edu/ir/uncg/f/C_Hooper_Visual_1997.pdf
Tea Association of the USA. (2013). Tea Fact Sheet. Retrieved October 25, 2014,
from http://www.teausa.com/14655/tea-fact-sheet
Van der Watt, G., Laugharne, J., & Janca, A. (2008). Complementary and alternative
medicine in the treatment of anxiety and depression. Current Opinion in
Psychiatry, 21(1), 37–42. doi:10.1097/YCO.0b013e3282f2d814
Vuong, Q. V, Bowyer, M. C., & Roach, P. D. (2011). L-Theanine: properties, synthesis
and isolation from tea. Journal of the Science of Food and Agriculture, 91(11),
1931–9. doi:10.1002/jsfa.4373
Yang, C. S., Chen, G., & Wu, Q. (2014). Recent scientific studies of a traditional
chinese medicine, tea, on prevention of chronic diseases. Journal of Traditional
and Complementary Medicine, 4(1), 17–23. doi:10.4103/2225-4110.124326

48

